1. Pink Sheet

FDA Vectibix Review Posits Study Design Issues That Could Have Led To Lack Of Survival Benefit

 
• By Tamra Sami

Review documents for the biologic show disagreement between statistical and medical reviewers over utility of progression-free survival in predicting an overall survival benefit.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Pink Sheet